Sign Out
Adverse events are listed as follows by system organ class and frequency. Frequencies are defined as: very common (≥1/10), common (≥1/100, <1/10), uncommon (≥1/1,000, <1/100), rare (≥1/10,000, <1/1,000), very rare (<1/10,000), including isolated reports.
Clinical Trial Data: The tables as follows list the adverse drug reactions reported at a higher rate with ropinirole than placebo or a higher or comparable rate to comparator in clinical trials.
Adverse Drug Reactions Reported from Patients with Parkinson's Disease: Unless otherwise indicated, the data in the following table was observed with both immediate release and prolonged release formulations. (See Table 2).
Click on icon to see table/diagram/imageAdverse Drug Reactions Reported During Clinical Trials in Patients with Restless Legs Syndrome: (see Table 3.)
Click on icon to see table/diagram/imagePost-Marketing Data: (see Table 4.)
Click on icon to see table/diagram/image
View ADR Reporting Link
Continue with Google